- Home
- SUPN vs MYRG Comparison
SUPN vs MYRG Comparison
Compare SUPN & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- MYRG
- Stock Information
- Founded
- SUPN 2005
- MYRG 1891
- Country
- SUPN United States
- MYRG United States
- Employees
- SUPN N/A
- MYRG N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- MYRG Water Sewer Pipeline Comm & Power Line Construction
- Sector
- SUPN Health Care
- MYRG Industrials
- Exchange
- SUPN Nasdaq
- MYRG Nasdaq
- Market Cap
- SUPN 2.1B
- MYRG 2.3B
- IPO Year
- SUPN 2012
- MYRG N/A
- Fundamental
- Price
- SUPN $37.74
- MYRG $147.72
- Analyst Decision
- SUPN Hold
- MYRG Strong Buy
- Analyst Count
- SUPN 1
- MYRG 5
- Target Price
- SUPN $36.00
- MYRG $162.40
- AVG Volume (30 Days)
- SUPN 376.5K
- MYRG 210.7K
- Earning Date
- SUPN 02-25-2025
- MYRG 02-26-2025
- Dividend Yield
- SUPN N/A
- MYRG N/A
- EPS Growth
- SUPN 130.79
- MYRG N/A
- EPS
- SUPN 1.07
- MYRG 2.29
- Revenue
- SUPN $651,972,000.00
- MYRG $3,536,692,000.00
- Revenue This Year
- SUPN $7.82
- MYRG N/A
- Revenue Next Year
- SUPN N/A
- MYRG $2.93
- P/E Ratio
- SUPN $35.28
- MYRG $64.45
- Revenue Growth
- SUPN 6.79
- MYRG 0.94
- 52 Week Low
- SUPN $25.53
- MYRG $86.60
- 52 Week High
- SUPN $39.37
- MYRG $181.02
- Technical
- Relative Strength Index (RSI)
- SUPN 57.78
- MYRG 47.93
- Support Level
- SUPN $36.48
- MYRG $138.29
- Resistance Level
- SUPN $38.68
- MYRG $149.60
- Average True Range (ATR)
- SUPN 1.06
- MYRG 4.90
- MACD
- SUPN 0.09
- MYRG -0.40
- Stochastic Oscillator
- SUPN 68.46
- MYRG 54.70
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About MYRG MYR Group Inc.
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution network and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.